Rhumbline Advisers Twist Bioscience Corp Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Twist Bioscience Corp stock. As of the latest transaction made, Rhumbline Advisers holds 92,897 shares of TWST stock, worth $4.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,897

Previous 100,967 7.99%

Holding current value

$4.22 Million

Previous $3.46 Million 32.13%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$27.95 - $53.0 $225,556 - $427,710	-8,070 Reduced 7.99%	92,897 $4.58 Million
Q1 2024 May 09, 2024	BUY	$32.28 - $41.5 $118,564 - $152,429	3,673 Added 3.78%	100,967 $3.46 Million
Q4 2023 Feb 08, 2024	SELL	$15.08 - $38.61 $3,770 - $9,652	-250 Reduced 0.26%	97,294 $3.59 Million
Q3 2023 Nov 09, 2023	SELL	$18.62 - $26.57 $308,570 - $440,318	-16,572 Reduced 14.52%	97,544 $1.98 Million
Q2 2023 Aug 08, 2023	BUY	$11.49 - $20.46 $369,139 - $657,318	32,127 Added 39.18%	114,116 $2.33 Million
Q1 2023 May 11, 2023	BUY	$14.6 - $30.9 $21,491 - $45,484	1,472 Added 1.83%	81,989 $1.24 Million
Q4 2022 Feb 14, 2023	BUY	$21.92 - $39.37 $56,159 - $100,865	2,562 Added 3.29%	80,517 $1.92 Million
Q3 2022 Nov 10, 2022	BUY	$33.44 - $56.56 $170,978 - $289,191	5,113 Added 7.02%	77,955 $2.75 Million
Q2 2022 Aug 11, 2022	BUY	$26.2 - $54.0 $430,570 - $887,436	16,434 Added 29.13%	72,842 $2.55 Million
Q1 2022 May 12, 2022	BUY	$38.58 - $83.27 $235,723 - $508,779	6,110 Added 12.15%	56,408 $2.79 Million
Q4 2021 Feb 10, 2022	SELL	$75.47 - $135.88 $47,772 - $86,012	-633 Reduced 1.24%	50,298 $3.89 Million
Q3 2021 Nov 12, 2021	BUY	$95.64 - $131.48 $113,142 - $155,540	1,183 Added 2.38%	50,931 $5.45 Million
Q2 2021 Aug 05, 2021	SELL	$88.13 - $142.06 $133,076 - $214,510	-1,510 Reduced 2.95%	49,748 $6.63 Million
Q1 2021 May 06, 2021	BUY	$105.48 - $207.97 $1.09 Million - $2.14 Million	10,290 Added 25.12%	51,258 $6.35 Million
Q4 2020 Feb 10, 2021	BUY	$76.64 - $167.89 $146,382 - $320,669	1,910 Added 4.89%	40,968 $5.79 Million
Q3 2020 Nov 12, 2020	SELL	$45.46 - $78.79 $248,757 - $431,138	-5,472 Reduced 12.29%	39,058 $2.97 Million
Q2 2020 Aug 13, 2020	BUY	$26.4 - $45.3 $319,968 - $549,036	12,120 Added 37.4%	44,530 $2.02 Million
Q1 2020 May 06, 2020	BUY	$19.71 - $35.15 $133,180 - $237,508	6,757 Added 26.34%	32,410 $991,000
Q4 2019 Feb 05, 2020	BUY	$21.0 - $26.48 $13,188 - $16,629	628 Added 2.51%	25,653 $539,000
Q3 2019 Oct 23, 2019	BUY	$23.72 - $33.99 $3,320 - $4,758	140 Added 0.56%	25,025 $598,000
Q2 2019 Aug 14, 2019	BUY	$21.74 - $33.2 $540,999 - $826,182	24,885 New	24,885 $722,000

Others Institutions Holding TWST

# of Institutions

273

Shares Held

66.1M

Call Options Held

209K

Put Options Held

111K

View Full List

About Twist Bioscience Corp

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.56B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

More about TWST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Twist Bioscience Corp Transaction History